<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[Dexa Group]]></title><description><![CDATA[Dexa Group]]></description><link>https://www.dexagroup.com/blog</link><generator>RSS for Node</generator><lastBuildDate>Fri, 09 Oct 2026 13:45:03 GMT</lastBuildDate><atom:link href="https://www.dexagroup.com/id/blog-feed.xml" rel="self" type="application/rss+xml"/><item><title><![CDATA[Fonko Perkuat Kapasitas Industri Onkologi Indonesia]]></title><description><![CDATA[JAKARTA – PT Fonko International Pharmaceuticals mencatat sejumlah milestone dalam pengembangan manufaktur obat onkologi di Indonesia. Pencapaian tersebut mencakup keberhasilan memperoleh sertifikasi European Union Good Manufacturing Practice (EU GMP) pada 2025, pengembangan sejumlah produk first copy untuk terapi kanker, serta pemenuhan sertifikasi halal untuk seluruh produk onkologi yang diproduksi. Perjalanan tersebut melanjutkan komitmen Fonko dalam membangun kapasitas produksi obat...]]></description><link>https://www.dexagroup.com/id/post/fonko-perkuat-kapasitas-industri-onkologi-indonesia</link><guid isPermaLink="false">6abf515ec490038e9ef728f2</guid><category><![CDATA[Berita]]></category><pubDate>Wed, 30 Sep 2026 17:00:00 GMT</pubDate><enclosure url="https://static.wixstatic.com/media/cc3bbb_981d03c49e53448fb7ae660ab35c55c6~mv2.jpeg/v1/fit/w_992,h_662,al_c,q_80/file.png" length="0" type="image/png"/><dc:creator>Praditya Kasworo</dc:creator></item><item><title><![CDATA[Fonko Strengthens Indonesia's Oncology Industry Capacity]]></title><description><![CDATA[JAKARTA — PT Fonko International Pharmaceuticals has recorded several key milestones in the development of oncology drug manufacturing in Indonesia. These achievements include securing European Union Good Manufacturing Practice (EU GMP) certification in 2025, developing a range of “first copy” products for cancer therapy, and obtaining halal certification for its entire oncology product line. This progress builds on Fonko’s ongoing commitment to expanding domestic production capacity for...]]></description><link>https://www.dexagroup.com/post/fonko-strengthens-indonesia-s-oncology-industry-capacity</link><guid isPermaLink="false">6abf500c85cf782c00a99e79</guid><category><![CDATA[News]]></category><pubDate>Wed, 30 Sep 2026 17:00:00 GMT</pubDate><enclosure url="https://static.wixstatic.com/media/cc3bbb_981d03c49e53448fb7ae660ab35c55c6~mv2.jpeg/v1/fit/w_992,h_662,al_c,q_80/file.png" length="0" type="image/png"/><dc:creator>Praditya Kasworo</dc:creator></item><item><title><![CDATA[Consistently Maintaining Halal Standards, Dexa Group Wins IHYA 2026]]></title><description><![CDATA[TANGERANG — PT Ferron Par Pharmaceuticals, a member of Dexa Group, has won the 2026 Indonesia Halal Industry Award (IHYA) from the Ministry of Industry of the Republic of Indonesia in the Large Industrial Enterprise Category, Subcategory of Best Pharmaceuticals and Traditional Medicines. This award recognizes Dexa Group’s consistency in implementing the Halal Product Assurance System (SJPH). To date, all of Dexa Group’s production facilities and products have been certified halal. This...]]></description><link>https://www.dexagroup.com/post/consistently-maintaining-halal-standards-dexa-group-wins-ihya-2026</link><guid isPermaLink="false">6ab9ed1bc78acb9707b46bab</guid><category><![CDATA[Award]]></category><category><![CDATA[News]]></category><pubDate>Thu, 24 Sep 2026 17:00:00 GMT</pubDate><enclosure url="https://static.wixstatic.com/media/cc3bbb_2a9a7eb4bbbe4fd1a0efcf024a57be6c~mv2.jpeg/v1/fit/w_1000,h_854,al_c,q_80/file.png" length="0" type="image/png"/><dc:creator>Praditya Kasworo</dc:creator></item><item><title><![CDATA[Konsisten Menjaga Standar Halal, Dexa Group Raih IHYA 2026]]></title><description><![CDATA[TANGERANG — PT Ferron Par Pharmaceuticals, perusahaan bagian dari Dexa Group, meraih Indonesia Halal Industry Awards (IHYA) 2026 dari Kementerian Perindustrian RI untuk kategori Perusahaan Industri Besar, Subkategori Farmasi dan Obat Tradisional Terbaik. Penghargaan ini menjadi pengakuan atas konsistensi Dexa Group dalam menerapkan Sistem Jaminan Produk Halal (SJPH). Hingga saat ini, seluruh fasilitas produksi dan produk Dexa Group telah tersertifikasi halal. Komitmen ini membawa pesan kepada...]]></description><link>https://www.dexagroup.com/id/post/konsisten-menjaga-standar-halal-dexa-group-raih-ihya-2026</link><guid isPermaLink="false">6ab9edda0af5ff5885f343df</guid><category><![CDATA[Penghargaan]]></category><category><![CDATA[Berita]]></category><pubDate>Thu, 24 Sep 2026 17:00:00 GMT</pubDate><enclosure url="https://static.wixstatic.com/media/cc3bbb_2a9a7eb4bbbe4fd1a0efcf024a57be6c~mv2.jpeg/v1/fit/w_1000,h_854,al_c,q_80/file.png" length="0" type="image/png"/><dc:creator>Praditya Kasworo</dc:creator></item><item><title><![CDATA[From Medications to Facilities, Ferron Strengthens Support for Cancer Patients]]></title><description><![CDATA[JAKARTA — Indonesia recorded 474,083 new cases and 283,299 deaths due to cancer, according to 2024 Global Cancer Observatory (GLOBOCAN) data. This situation underscores the critical role of Ferron Par Pharmaceuticals in expanding its support for cancer patients—from delivering access to medications to strengthening chemotherapy support facilities through the provision of Cytostatic Drug Preparation Units (TPO Sitostatika) in more than 10 hospitals across Indonesia, including the recent...]]></description><link>https://www.dexagroup.com/post/from-medications-to-facilities-ferron-strengthens-support-for-cancer-patients</link><guid isPermaLink="false">6ab9ea4ae3d652319309b2bc</guid><category><![CDATA[News]]></category><pubDate>Wed, 23 Sep 2026 17:00:00 GMT</pubDate><enclosure url="https://static.wixstatic.com/media/cc3bbb_3a8af4bf5f3041e0a40eaac8c5c4db67~mv2.jpeg/v1/fit/w_1000,h_765,al_c,q_80/file.png" length="0" type="image/png"/><dc:creator>Praditya Kasworo</dc:creator></item><item><title><![CDATA[Dari Obat hingga Fasilitas, Ferron Perkuat Dukungan bagi Pasien Kanker]]></title><description><![CDATA[JAKARTA — Indonesia mencatat 474.083 kasus baru dan 283.299 kematian akibat kanker, berdasarkan data Global Cancer Observatory (GLOBOCAN) tahun 2024. Kondisi ini menegaskan peran Ferron Par Pharmaceuticals untuk memperluas dukungan bagi pasien kanker, dengan menghadirkan akses obat hingga memperkuat fasilitas yang menunjang layanan kemoterapi melalui penyediaan Tempat Penyiapan Obat (TPO) Sitostatika di lebih dari 10 rumah sakit di Indonesia, termasuk merenovasi TPO Sitostatika di RSUD Dr. H....]]></description><link>https://www.dexagroup.com/id/post/dari-obat-hingga-fasilitas-ferron-perkuat-dukungan-bagi-pasien-kanker</link><guid isPermaLink="false">6ab9eae6d1c7cc475d304796</guid><category><![CDATA[Berita]]></category><pubDate>Wed, 23 Sep 2026 17:00:00 GMT</pubDate><enclosure url="https://static.wixstatic.com/media/cc3bbb_3a8af4bf5f3041e0a40eaac8c5c4db67~mv2.jpeg/v1/fit/w_1000,h_765,al_c,q_80/file.png" length="0" type="image/png"/><dc:creator>Praditya Kasworo</dc:creator></item><item><title><![CDATA[Dharma Dexa Wujudkan "Deal with Care" bagi Masyarakat Terdampak Bencana 2026]]></title><description><![CDATA[JAKARTA — Di tengah rentetan bencana alam yang melanda berbagai penjuru Indonesia sepanjang tahun 2026, Dexa Group melalui Corporate Social Initiatives Dharma Dexa terus memperkuat komitmennya dalam menjaga kesehatan dan memberikan harapan bagi masyarakat terdampak. Langkah ini menjadi bagian dari semangat peringatan HUT ke-57 Dexa Group untuk menghadirkan kepedulian dalam berbagai bentuk sesuai dengan kebutuhan masing-masing wilayah. Ada warga yang membutuhkan obat, tempat untuk berteduh,...]]></description><link>https://www.dexagroup.com/id/post/dharma-dexa-wujudkan-deal-with-care-bagi-masyarakat-terdampak-bencana-2026</link><guid isPermaLink="false">6ab3705dc1bfc6e5fbf56b65</guid><category><![CDATA[Berita]]></category><pubDate>Tue, 22 Sep 2026 17:00:00 GMT</pubDate><enclosure url="https://static.wixstatic.com/media/cc3bbb_2d2c0a1c31674fa7b6df56885f0245d5~mv2.jpg/v1/fit/w_960,h_720,al_c,q_80/file.png" length="0" type="image/png"/><dc:creator>Praditya Kasworo</dc:creator></item><item><title><![CDATA[Dharma Dexa Implements “Deal with Care" for Disaster-Affected Communities in 2026]]></title><description><![CDATA[JAKARTA — Amid a series of natural disasters impacting various regions across Indonesia throughout 2026, Dexa Group, through its Corporate Social Initiative Dharma Dexa, continues to strengthen its commitment to safeguarding health and inspiring hope for affected communities. This step marks part of Dexa Group’s 57th-anniversary spirit to extend meaningful care tailored to the specific needs of each region. From medical supplies and shelter to preventive health protection and moral support,...]]></description><link>https://www.dexagroup.com/post/dharma-dexa-implements-deal-with-care-for-disaster-affected-communities-in-2026</link><guid isPermaLink="false">6ab36e64eb3689c8016537df</guid><category><![CDATA[News]]></category><pubDate>Tue, 22 Sep 2026 17:00:00 GMT</pubDate><enclosure url="https://static.wixstatic.com/media/cc3bbb_2d2c0a1c31674fa7b6df56885f0245d5~mv2.jpg/v1/fit/w_960,h_720,al_c,q_80/file.png" length="0" type="image/png"/><dc:creator>Praditya Kasworo</dc:creator></item><item><title><![CDATA[OGB Dexa Konsisten Perkuat Akses Obat Berkualitas bagi Masyarakat Indonesia]]></title><description><![CDATA[JAKARTA – Selama lebih dari tiga dekade, Dexa Group konsisten berkontribusi menyediakan obat berkualitas bagi masyarakat Indonesia melalui Obat Generik Berlogo (OGB) Dexa. Kini, OGB Dexa memproduksi lebih dari 2 miliar unit per tahun dengan lebih dari 140 SKU untuk mendukung program JKN. Kontribusi terhadap ketersediaan obat berkualitas dan terjangkau tersebut telah berlangsung sejak mulai diproduksi pada 1991. Pada tahun 1991, Dexa Medica merupakan perusahaan farmasi swasta pertama di...]]></description><link>https://www.dexagroup.com/id/post/ogb-dexa-konsisten-perkuat-akses-obat-berkualitas-bagi-masyarakat-indonesia</link><guid isPermaLink="false">6ab202ce55c272c9054915c5</guid><category><![CDATA[Berita]]></category><pubDate>Tue, 22 Sep 2026 04:25:31 GMT</pubDate><enclosure url="https://static.wixstatic.com/media/cc3bbb_3107b7256ea9422b956116a2de44040b~mv2.png/v1/fit/w_1000,h_1000,al_c,q_80/file.png" length="0" type="image/png"/><dc:creator>Praditya Kasworo</dc:creator></item><item><title><![CDATA[OGB Dexa Consistently Strengthens Access to Quality Medicines for Indonesia]]></title><description><![CDATA[JAKARTA – For more than three decades, Dexa Group has consistently contributed to providing quality medicines for the Indonesian people through Obat Generik Berlogo/OGB (unbranded generics) Dexa. Today, OGB Dexa produces more than 2 billion units annually with over 140 SKUs to support the National Health Insurance (JKN) program. This contribution to ensuring the availability of quality and affordable medicines has been ongoing since production began in 1991. In 1991, Dexa Medica became the...]]></description><link>https://www.dexagroup.com/post/ogb-dexa-consistently-strengthens-access-to-quality-medicines-for-indonesia</link><guid isPermaLink="false">6ab20227a6d8d9eec9342f62</guid><category><![CDATA[News]]></category><pubDate>Tue, 22 Sep 2026 04:23:28 GMT</pubDate><enclosure url="https://static.wixstatic.com/media/cc3bbb_3107b7256ea9422b956116a2de44040b~mv2.png/v1/fit/w_1000,h_1000,al_c,q_80/file.png" length="0" type="image/png"/><dc:creator>Praditya Kasworo</dc:creator></item><item><title><![CDATA[Inlacin® Bukti Kualitas Fitofarmaka Saintifik untuk Tata Laksana PMOS]]></title><description><![CDATA[JAKARTA – Secara global, kondisi yang selama ini dikenal sebagai polycystic ovary syndrome (PCOS) diperkirakan memengaruhi lebih dari 170 juta perempuan, atau sekitar satu dari delapan perempuan usia reproduktif. Besarnya prevalensi dan luasnya dampak kondisi ini mendasari konsensus global yang dipublikasikan dalam The Lancet pada 2026 untuk mengusulkan perubahan nama PCOS menjadi polyendocrine metabolic ovarian syndrome (PMOS). Nomenklatur tersebut dinilai lebih mencerminkan karakter...]]></description><link>https://www.dexagroup.com/id/post/inlacin-bukti-kualitas-fitofarmaka-saintifik-untuk-tata-laksana-pmos</link><guid isPermaLink="false">6ab9e825956f6773572be846</guid><category><![CDATA[Berita]]></category><pubDate>Mon, 21 Sep 2026 17:00:00 GMT</pubDate><enclosure url="https://static.wixstatic.com/media/cc3bbb_3743623f45c04419ba13f4f8b725e295~mv2.jpg/v1/fit/w_1000,h_896,al_c,q_80/file.png" length="0" type="image/png"/><dc:creator>Praditya Kasworo</dc:creator></item><item><title><![CDATA[Inlacin® Proves Quality of Scientific Phytopharmaceuticals for PMOS Management]]></title><description><![CDATA[JAKARTA — Globally, the condition long known as polycystic ovary syndrome (PCOS) is estimated to affect more than 170 million women, or approximately one in eight women of reproductive age. The vast prevalence and far-reaching impact of this condition led to a global consensus published in The Lancet in 2026, proposing a name change from PCOS to polyendocrine metabolic ovarian syndrome (PMOS). This new nomenclature is considered to better reflect the multisystem nature of the disorder, which...]]></description><link>https://www.dexagroup.com/post/inlacin-proves-quality-of-scientific-phytopharmaceuticals-for-pmos-management</link><guid isPermaLink="false">6ab9e754e3d652319309ad41</guid><category><![CDATA[News]]></category><pubDate>Mon, 21 Sep 2026 17:00:00 GMT</pubDate><enclosure url="https://static.wixstatic.com/media/cc3bbb_3743623f45c04419ba13f4f8b725e295~mv2.jpg/v1/fit/w_1000,h_896,al_c,q_80/file.png" length="0" type="image/png"/><dc:creator>Praditya Kasworo</dc:creator></item><item><title><![CDATA[Raih Predikat Summa Cum Laude dari UPH, Prof. Raymond Tjandrawinata Gagas Model Paten Farmasi Berkeadilan untuk Jamin Akses Obat Masyarakat]]></title><description><![CDATA[JAKARTA – Guru Besar Farmakologi Molekuler Universitas Atma Jaya sekaligus Farmakolog Molekuler Dexa Group, Prof. Raymond Tjandrawinata, sukses mempertahankan disertasi doktoralnya dalam Program Studi Hukum di Universitas Pelita Harapan (UPH) dengan predikat Summa Cum Laude. Melalui penelitian lintas disiplin yang memadukan kepakaran farmasi dan ilmu hukum, Prof. Raymond menyoroti urgensi sistem kesehatan nasional dalam menyeimbangkan perlindungan hak paten industri farmasi sekaligus menjamin...]]></description><link>https://www.dexagroup.com/id/post/raih-predikat-summa-cum-laude-dari-uph-prof-raymond-tjandrawinata-gagas-model-paten-farmasi-berkea</link><guid isPermaLink="false">6aab5a485dfcc7eff24f452a</guid><category><![CDATA[Berita]]></category><pubDate>Tue, 15 Sep 2026 17:00:00 GMT</pubDate><enclosure url="https://static.wixstatic.com/media/cc3bbb_02a6a62835364db89e137306d2981136~mv2.jpeg/v1/fit/w_1000,h_854,al_c,q_80/file.png" length="0" type="image/png"/><dc:creator>Praditya Kasworo</dc:creator></item><item><title><![CDATA[Dexa Group Molecular Pharmacologist Prof. Raymond Tjandrawinata Earns Summa Cum Laude Doctorate in Law, Proposes Equitable Pharmaceutical Patent Model]]></title><description><![CDATA[JAKARTA – Prof. Raymond Tjandrawinata, Professor of Molecular Pharmacology at Atma Jaya University and Molecular Pharmacologist at Dexa Group, has successfully completed his Doctor of Law degree at Universitas Pelita Harapan (UPH), graduating with the distinction of Summa Cum Laude His doctoral research brings together his expertise in pharmaceutical science and law, addressing the need for a healthcare and patent framework that balances the protection of pharmaceutical innovation with...]]></description><link>https://www.dexagroup.com/post/dexa-group-molecular-pharmacologist-prof-raymond-tjandrawinata-earns-summa-cum-laude-doctorate-in-l</link><guid isPermaLink="false">6aab58f739c7a6ef95423b05</guid><category><![CDATA[News]]></category><pubDate>Tue, 15 Sep 2026 17:00:00 GMT</pubDate><enclosure url="https://static.wixstatic.com/media/cc3bbb_02a6a62835364db89e137306d2981136~mv2.jpeg/v1/fit/w_1000,h_854,al_c,q_80/file.png" length="0" type="image/png"/><dc:creator>Praditya Kasworo</dc:creator></item><item><title><![CDATA[PERIXA 2026 Bahas Peran AI dan Precision Medicine dalam Transformasi Layanan Kesehatan]]></title><description><![CDATA[JAKARTA - Perkembangan kecerdasan buatan (Artificial Intelligence/AI) dan teknologi digital membawa perubahan signifikan dalam ekosistem kesehatan, mulai dari pengembangan obat, praktik klinis, hingga hubungan dokter dan pasien. Perubahan tersebut menjadi bahasan utama Pertemuan Ilmiah Berkala Dexa (PERIXA) 2026 yang mengangkat tema “Navigating the Bio-Digital Era to Heal Diverse Populations”, di Jakarta, Minggu 6 September 2026. Marketing Director PT Dexa Medica, Natalia Maria, mengatakan...]]></description><link>https://www.dexagroup.com/id/post/perixa-2026-bahas-peran-ai-dan-precision-medicine-dalam-transformasi-layanan-kesehatan</link><guid isPermaLink="false">6aa8d20515c7556ff2386077</guid><category><![CDATA[Berita]]></category><pubDate>Thu, 10 Sep 2026 17:00:00 GMT</pubDate><enclosure url="https://static.wixstatic.com/media/cc3bbb_27dd81275dcb4f23b90c4e21eeaaf37f~mv2.jpeg/v1/fit/w_1000,h_1000,al_c,q_80/file.png" length="0" type="image/png"/><dc:creator>Praditya Kasworo</dc:creator></item><item><title><![CDATA[Stimuno: 27 Years of Protecting the Immune System of Indonesian Families]]></title><description><![CDATA[JAKARTA – For 27 years, Stimuno has been an integral part of the health journey for Indonesian families. Since its debut in 1999, this natural immunomodulator medication has accompanied families across generations, helping maintain strong immune systems so the body is better prepared to face various health challenges. Stimuno’s long journey is a testament to its consistency in delivering products tailored to family needs, earning lasting trust through uncompromised quality standards. Public...]]></description><link>https://www.dexagroup.com/post/stimuno-27-years-of-protecting-the-immune-system-of-indonesian-families</link><guid isPermaLink="false">6aa8cb80c1c672fb67417779</guid><category><![CDATA[Award]]></category><category><![CDATA[News]]></category><pubDate>Thu, 10 Sep 2026 17:00:00 GMT</pubDate><enclosure url="https://static.wixstatic.com/media/cc3bbb_3f063b7131ef431098fd7f1972fec16d~mv2.jpeg/v1/fit/w_1000,h_1000,al_c,q_80/file.png" length="0" type="image/png"/><dc:creator>Praditya Kasworo</dc:creator></item><item><title><![CDATA[Stimuno, 27 Tahun Melindungi Imun Keluarga Indonesia]]></title><description><![CDATA[JAKARTA – Selama 27 tahun, Stimuno telah menjadi bagian dari perjalanan kesehatan keluarga Indonesia. Sejak hadir pada 1999, obat bahan alam yang berkhasiat sebagai imunomodulator ini terus mendampingi keluarga dari generasi ke generasi dalam membantu menjaga sistem imun agar tubuh lebih siap menghadapi berbagai tantangan kesehatan. Perjalanan panjang Stimuno menjadi bukti konsistensi dalam menghadirkan produk yang relevan dengan kebutuhan keluarga, sekaligus menjaga kepercayaan melalui...]]></description><link>https://www.dexagroup.com/id/post/stimuno-27-tahun-melindungi-imun-keluarga-indonesia</link><guid isPermaLink="false">6aa8cc384c1132765565b799</guid><category><![CDATA[Penghargaan]]></category><category><![CDATA[Berita]]></category><pubDate>Thu, 10 Sep 2026 17:00:00 GMT</pubDate><enclosure url="https://static.wixstatic.com/media/cc3bbb_3f063b7131ef431098fd7f1972fec16d~mv2.jpeg/v1/fit/w_1000,h_1000,al_c,q_80/file.png" length="0" type="image/png"/><dc:creator>Praditya Kasworo</dc:creator></item><item><title><![CDATA[PERIXA 2026 Discusses the Role of AI and Precision Medicine in Healthcare Transformation]]></title><description><![CDATA[JAKARTA — The rapid growth of Artificial Intelligence (AI) and digital technology is driving significant shifts across the healthcare ecosystem—from drug discovery and clinical practice to doctor-patient dynamics. These transformations formed the core discussion at the 2026 Dexa Periodic Scientific Meeting (PERIXA), which carried the theme “Navigating the Bio-Digital Era to Heal Diverse Populations” in Jakarta on Sunday, September 6, 2026. Natalia Maria, Marketing Director of PT Dexa Medica,...]]></description><link>https://www.dexagroup.com/post/perixa-2026-discusses-the-role-of-ai-and-precision-medicine-in-healthcare-transformation</link><guid isPermaLink="false">6aa8cd73abcfc8d624a4e674</guid><category><![CDATA[News]]></category><pubDate>Thu, 10 Sep 2026 17:00:00 GMT</pubDate><enclosure url="https://static.wixstatic.com/media/cc3bbb_27dd81275dcb4f23b90c4e21eeaaf37f~mv2.jpeg/v1/fit/w_1000,h_1000,al_c,q_80/file.png" length="0" type="image/png"/><dc:creator>Praditya Kasworo</dc:creator></item><item><title><![CDATA[Promoting Sustainable Healthy Lifestyles, Dexa Group Offers Free Health Screenings at Wellfest 2026]]></title><description><![CDATA[SOUTH TANGERANG – A healthy lifestyle is more than a passing trend; it is an essential part of maintaining long-term quality of life. This message was at the heart of the Indonesia Wellness Festival (Wellfest) 2026, themed “The New Paradigm of Sustainable Living,” held from September 4–6, 2026, at Bintaro Jaya Xchange Mall, South Tangerang. In line with this spirit, Dexa Group participated by presenting various activities encouraging the public to pay greater attention to their health. Among...]]></description><link>https://www.dexagroup.com/post/promoting-sustainable-healthy-lifestyles-dexa-group-offers-free-health-screenings-at-wellfest-2026</link><guid isPermaLink="false">6aa3aa59f448a9cd17b29db4</guid><category><![CDATA[News]]></category><pubDate>Mon, 07 Sep 2026 17:00:00 GMT</pubDate><enclosure url="https://static.wixstatic.com/media/cc3bbb_8e84397133964eeea875393f1ed4f335~mv2.jpeg/v1/fit/w_1000,h_853,al_c,q_80/file.png" length="0" type="image/png"/><dc:creator>Praditya Kasworo</dc:creator></item><item><title><![CDATA[Dorong Gaya Hidup Sehat Berkelanjutan, Dexa Group Hadirkan Cek Kesehatan Gratis di Wellfest 2026]]></title><description><![CDATA[TANGERANG SELATAN – Gaya hidup sehat lebih dari sebuah tren dan menjadi bagian dari upaya menjaga kualitas hidup dalam jangka panjang. Hal ini dimaknai dalam Indonesia Wellnes Festival (Wellfest) 2026 bertemakan “The New Paradigm of Sustainable Living” pada 4–6 September 2026 di Bintaro Jaya Xchange Mall, Tangerang Selatan. Sejalan dengan semangat tersebut, Dexa Group turut berpartisipasi dengan menghadirkan berbagai aktivitas yang mengajak masyarakat lebih peduli terhadap Kesehatan, salah...]]></description><link>https://www.dexagroup.com/id/post/dorong-gaya-hidup-sehat-berkelanjutan-dexa-group-hadirkan-cek-kesehatan-gratis-di-wellfest-2026</link><guid isPermaLink="false">6aa3ab342beaa48e73767259</guid><category><![CDATA[Berita]]></category><pubDate>Mon, 07 Sep 2026 17:00:00 GMT</pubDate><enclosure url="https://static.wixstatic.com/media/cc3bbb_8e84397133964eeea875393f1ed4f335~mv2.jpeg/v1/fit/w_1000,h_853,al_c,q_80/file.png" length="0" type="image/png"/><dc:creator>Praditya Kasworo</dc:creator></item></channel></rss>